The Cancer Spit Test Device Market is experiencing robust growth, driven by the increasing global cancer burden and the surging demand for non-invasive, quick, and user-friendly diagnostic solutions. Saliva-based diagnostics, or "spit tests," offer a pain-free, cost-effective, and convenient alternative to traditional blood-based liquid biopsies and invasive tissue biopsies. This...